الصفحة الرئيسية>>Signaling Pathways>> Membrane Transporter/Ion Channel>> GlyT>>PF-03463275

PF-03463275

رقم الكتالوجGC60284

PF-03463275 هو مثبط قابل للاختراق مركزيًا ، ومتاح شفهيًا ، وانتقائي ، وتنافسي GlyT1 (ناقل الجليسين -1) ، مع Ki يبلغ 11.6 نانومتر

Products are for research use only. Not for human use. We do not sell to patients.

PF-03463275 التركيب الكيميائي

Cas No.: 1173239-39-8

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
116٫00
متوفر
5mg
200٫00
متوفر
10mg
336٫00
متوفر
50mg
770٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PF-03463275 is a centrally penetrant, orally available, selective, and competitive GlyT1 (glycine transporter-1) reversible inhibitor, with a Ki of 11.6 nM. PF-03463275 has the potential for Schizophrenia research[1][2].

PF-03463275 (1-10 mg/kg; s.c.) attenuates oscillatory potentials (OPs)[2]. Animal Model: Male Sprague-Dawley rats[2]

[1]. Lowe JA 3rd, et al. The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter [published correction appears in Bioorg Med Chem Lett. 2009 Aug 15;19(16):4885. Bronk, Brian S [added]; Schaeffer, Eric [added]]. Bioorg Med Chem Lett. 2009;19(11):2974-2976. [2]. Liu CN, Pettersen B, Seitis G, Osgood S, Somps C. GlyT1 inhibitor reduces oscillatory potentials of the electroretinogram in rats. Cutan Ocul Toxicol. 2014;33(3):206-211.

مراجعات

Review for PF-03463275

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PF-03463275

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.